Category Added in a WPeMatico Campaign
Objectives: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disorder. Data regarding the reported triggers of this rare […]
Background: Nintedanib, a tyrosine kinase inhibitor with antifibrotic properties, has been shown to significantly slow the progression of pulmonary fibrosis.
Background/Objective: Pulmonary involvement of Behçet disease (BD) typically manifests as vascular involvement in the form of pulmonary artery thrombosis and/or
Objective: The study objectives were to compare the characteristics of patients with giant cell arteritis (GCA) from nonrural and rural
Objective: Cardiovascular disease (CVD) remains the leading cause of mortality in systemic lupus erythematosus (SLE). This study compared the performance
Objective: Juvenile idiopathic arthritis is a heterogeneous group of chronic childhood arthritis. We planned to classify patients with oligoarticular, rheumatoid
Objective: To develop a score for a diagnosis of cytopenias from systemic lupus erythematosus (SLE) activity and determine the usefulness
Background: Reproductive health is a critical issue for women with autoimmune rheumatic diseases (ARDs), yet significant gaps in knowledge and
Objective: This study seeks to assess the temporal patterns of osteoarthritis (OA) in Mexico from 1990 to 2021 using the
Objective: Biological drugs have revolutionized the treatment of rheumatic diseases, but their high cost has contributed to increased prescription drug
Background: Options for systemic sclerosis–associated interstitial lung disease (SSc-ILD) have evolved rapidly. Mycophenolate mofetil (MMF) has replaced cyclophosphamide (CYC) in
Objective: To describe Raynaud phenomenon (RP) management practices for systemic sclerosis (SSc) patients among US community-based rheumatologists. Methods: We identified
Although antinuclear antibody (ANA) positivity on HEp-2 cells is a mandatory criterion for the classification of systemic lupus erythematosus (SLE),
Background: Psoriatic arthritis (PsA) is a complex immune-mediated heterogeneous inflammatory disease. Treatment decisions are challenging given the multisystem involvement. To
Objective: To evaluate the HALP (hemoglobin-albumin-lymphocyte-platelet) score at lupus nephritis (LN) diagnosis in predicting renal relapse (RR). Methods: Nested case-control
Purpose: To assess whether sex and comorbidity are associated with the risk of 90-day readmission and associated mortality after nonelective
Objective To create an affordable, easily reproducible, low-fidelity hand model and present a validity argument for its use to support
Objective Gout follow-up after an emergency department (ED) visit for gout flare may improve outcomes, which could be influenced by
This study aimed to investigate the association between methotrexate (MTX) response in rheumatoid arthritis and the polymorphisms methionine synthase reductase
Objective To evaluate the timing of uveitis onset in patients with oligoarticular juvenile idiopathic arthritis (oJIA) and to identify clinical
Background Axial spondyloarthritis (axSpA) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, with anterior uveitis (AU)
Background Project ECHO (Extension for Community Healthcare Outcomes) links experts with community providers through video teleconferences that include both didactics
Background Janus kinase (JAK) inhibitors have been approved for treating psoriatic arthritis (PsA); however, the comparative efficacy of different JAK
Background Idiopathic inflammatory myopathies (IIMs) are rare autoimmune diseases with limited epidemiological data from Latin America. Objective To characterize IIMs
Objective The prevalence of juvenile-onset systemic lupus erythematosus (JSLE) differs by race/ethnicity with environmental, genetic, and social factors implicated in
Background/Objective This study assessed the outcomes of patients with antineutrophil cytoplasm antibody–associated vasculitis glomerulonephritis (AAV-GN). Methods This historical cohort study
